Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Study of treatments for pyoderma gangrenosum
ISRCTN35898459Phase 4Completed
- Sponsor
- Nottingham University Hospitals
- Start
- Jun 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Peptides
01
Overview
Phase 4, randomised, open-label trial of prednisolone and cyclosporine in pyoderma gangrenosum (PG) (3 arms), sponsored by Nottingham University Hospitals. Primary endpoint: Velocity of healing at 6 weeks. Started Jun 2009; status: completed.
02
Drugs
prednisolonecyclosporine
03
Conditions
pyoderma gangrenosum (PG)
Beyond the preview
Go deeper on ISRCTN35898459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN35898459.